Literature DB >> 19913141

Forgettable contraception.

David A Grimes1.   

Abstract

The term "forgettable contraception" has received less attention in family planning than has "long-acting reversible contraception." Defined here as a method requiring attention no more often than every 3 years, forgettable contraception includes sterilization (female or male), intrauterine devices, and implants. Five principal factors determine contraceptive effectiveness: efficacy, compliance, continuation, fecundity, and the timing of coitus. Of these, compliance and continuation dominate; the key determinants of contraceptive effectiveness are human, not pharmacological. Human nature undermines methods with high theoretical efficacy, such as oral contraceptives and injectable contraceptives. By obviating the need to think about contraception for long intervals, forgettable contraception can help overcome our human fallibility. As a result, all forgettable contraception methods provide first-tier effectiveness (</=2 pregnancies per 100 women per year) in typical use. Stated alternatively, the only class of contraceptives today with exclusively first-tier effectiveness is the one that can be started -- and then forgotten for years.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913141     DOI: 10.1016/j.contraception.2009.06.005

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  15 in total

1.  Evaluation of a volunteer community-based health worker program for providing contraceptive services in Madagascar.

Authors:  Maria F Gallo; Jenny Walldorf; Robert Kolesar; Aarti Agarwal; Athena P Kourtis; Denise J Jamieson; Alyssa Finlay
Journal:  Contraception       Date:  2013-06-15       Impact factor: 3.375

2.  Desire for Sterilization Reversal Among U.S. Females: Increasing Inequalities by Educational Level.

Authors:  Mieke C W Eeckhaut; Megan M Sweeney; Lei Feng
Journal:  Perspect Sex Reprod Health       Date:  2018-08-10

3.  Who is using long-acting reversible contraceptive methods? Findings from nine low-fertility countries.

Authors:  Mieke C W Eeckhaut; Megan M Sweeney; Jessica D Gipson
Journal:  Perspect Sex Reprod Health       Date:  2014-07-14

4.  Intrauterine devices at six months: does patient age matter? Results from an urban family medicine federally qualified health center (FQHC) network.

Authors:  Anita Ravi; Linda Prine; Eve Waltermaurer; Natasha Miller; Susan E Rubin
Journal:  J Am Board Fam Med       Date:  2014 Nov-Dec       Impact factor: 2.657

5.  Marital status and female and male contraceptive sterilization in the United States.

Authors:  Mieke Carine Wim Eeckhaut
Journal:  Fertil Steril       Date:  2015-04-14       Impact factor: 7.329

6.  Comparison of contraceptive use between the Contraceptive CHOICE Project and state and national data.

Authors:  Nupur D Kittur; Gina M Secura; Jeffrey F Peipert; Tessa Madden; Lawrence B Finer; Jenifer E Allsworth
Journal:  Contraception       Date:  2010-11-23       Impact factor: 3.375

7.  Understanding prescription adherence: pharmacy claims data from the Contraceptive CHOICE Project.

Authors:  Meredith E Pittman; Gina M Secura; Jenifer E Allsworth; Juell B Homco; Tessa Madden; Jeffrey F Peipert
Journal:  Contraception       Date:  2010-09-17       Impact factor: 3.375

8.  The perplexing links between contraceptive sterilization and (dis)advantage in ten low-fertility countries.

Authors:  Mieke C W Eeckhaut; Megan M Sweeney
Journal:  Popul Stud (Camb)       Date:  2016-01-21

Review 9.  Skin patch and vaginal ring versus combined oral contraceptives for contraception.

Authors:  Laureen M Lopez; David A Grimes; Maria F Gallo; Laurie L Stockton; Kenneth F Schulz
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

10.  Immediate vs. delayed insertion of intrauterine contraception after second trimester abortion: study protocol for a randomized controlled trial.

Authors:  Wendy V Norman; Janusz Kaczorowski; Judith A Soon; Rollin Brant; Stirling Bryan; Konia J Trouton; Lyda Dicus
Journal:  Trials       Date:  2011-06-14       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.